Samrat Pharmachem Ltd. Closes Trading Window from April 1, 2026, till 48 hours post Audited Financial Results Declaration

Samrat Pharmachem Ltd. has announced the closure of its trading window from April 1, 2026, till 48 hours after the declaration of the Audited Financial Results for the year ending March 31, 2026. This move is in compliance with the SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's 'Code of Conduct for Prevention of Insider Trading'. The trading window closure applies to all designated persons, including their immediate relatives, who are prohibited from dealing in any transaction involving sale, purchase, or pledge of shares of the company during this period. The company emphasizes that no employee or insider should deal in the shares of the company while in possession of Unpublished Price Sensitive Information.